336 related articles for article (PubMed ID: 8876023)
1. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.
Pälvimäki EP; Roth BL; Majasuo H; Laakso A; Kuoppamäki M; Syvälahti E; Hietala J
Psychopharmacology (Berl); 1996 Aug; 126(3):234-40. PubMed ID: 8876023
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
[TBL] [Abstract][Full Text] [Related]
3. Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
Laakso A; Pälvimäki EP; Kuoppamäki M; Syvälahti E; Hietala J
Neuropsychopharmacology; 1996 Aug; 15(2):143-51. PubMed ID: 8840350
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
Syvälahti E; Penttilä J; Majasuo H; Pälvimäki EP; Laakso A; Hietala J
Pharmacopsychiatry; 2006 Jan; 39(1):1-8. PubMed ID: 16453246
[TBL] [Abstract][Full Text] [Related]
5. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain.
Narita N; Hashimoto K; Tomitaka S; Minabe Y
Eur J Pharmacol; 1996 Jun; 307(1):117-9. PubMed ID: 8831113
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats.
Lightowler S; Wood M; Brown T; Glen A; Blackburn T; Tulloch I; Kennett G
Eur J Pharmacol; 1996 Jan; 296(2):137-43. PubMed ID: 8838449
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
Kuoppamäki M; Pälvimäki EP; Hietala J; Syvälahti E
Neuropsychopharmacology; 1995 Oct; 13(2):139-50. PubMed ID: 8597525
[TBL] [Abstract][Full Text] [Related]
9. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Oct; 269(2):201-8. PubMed ID: 7851496
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments.
Pälvimäki EP; Laakso A; Kuoppamäki M; Syvälahti E; Hietala J
Psychopharmacology (Berl); 1994 Aug; 115(4):543-6. PubMed ID: 7871100
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
Millan MJ; Gobert A; Rivet JM; Adhumeau-Auclair A; Cussac D; Newman-Tancredi A; Dekeyne A; Nicolas JP; Lejeune F
Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339
[TBL] [Abstract][Full Text] [Related]
12. Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation.
Pälvimäki EP; Majasuo H; Kuoppamäki M; Männistö PT; Syvälahti E; Hietala J
Psychopharmacology (Berl); 1998 Mar; 136(2):99-104. PubMed ID: 9551765
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
[TBL] [Abstract][Full Text] [Related]
14. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.
Clenet F; De Vos A; Bourin M
Eur Neuropsychopharmacol; 2001 Apr; 11(2):145-52. PubMed ID: 11313160
[TBL] [Abstract][Full Text] [Related]
15. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Sánchez C; Meier E
Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
[TBL] [Abstract][Full Text] [Related]
16. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
Wolf WA; Schutz LJ
J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Klimek V; Zak-Knapik J; Mackowiak M
J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis.
Dhami KS; Churchward MA; Baker GB; Todd KG
J Neurochem; 2019 Mar; 148(6):761-778. PubMed ID: 30613984
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Vicente MA; Zangrossi H
Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
